Skip to NavigationSkip to content

Clinigen chief executive joins Ergomed board

Published on: 28/05/14

UK drug development
 services firm Ergomed has appointed Peter George to its
board as a non-executive director.


George has over 20 years’ experience in the
industry and is currently chief executive of speciality pharma services firm the Clinigen Group. 

Prior to Clinigen he was chief executive at Penn Pharma, and previously was
executive VP for Wolters Kluwer Health with responsibility for Europe and
Asia-Pacific regions.

George has also held roles as the chief operating
officer of Unilabs Clinical Trials International Limited; head of Clinical
Pathology NHS and as director of PharmaPatents Global.

Chairman of Ergomed Rolf Stahel says: “We are delighted that
Peter has joined Ergomed as non-executive director. He has an excellent
track record of building international pharmaceutical services businesses.”

George adds: “I am very
pleased to join the board of Ergomed. The company has shown strong growth
since its inception 15 years ago and I have been very impressed with the
expertise and quality within the company. I believe Ergomed has great
potential and look forward to being a part of the team.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches